Suppr超能文献

绿茶树叶聚合物纳米颗粒的乙醇和乙酸乙酯馏分对乳腺癌细胞系MDA-MB-132的细胞毒性和抗增殖活性。

Cytotoxicity and antiproliferative activity of ethanol and ethyl acetate fractions from polymeric nanoparticles of green tea leaves () in breast cancer cell line MDA-MB-132.

作者信息

Kusmiyati Mimin, Rusdin Agus, Trinovani Elvi, Prawira-Atmaja M Iqbal, Purkon Dicki Bakhtiar, Mulyo Gurid Pramintarto Eko

机构信息

Poltekkes Kemenkes Bandung, Pharmacy Department, Indonesia.

Universitas Padjadjaran, Padjadjaran, Indonesia.

出版信息

J Adv Pharm Technol Res. 2022 Oct-Dec;13(4):301-305. doi: 10.4103/japtr.japtr_422_22. Epub 2022 Oct 10.

Abstract

Green tea () has benefits. Its main potential content is epigallocatechin gallate, which has many bioactivity and pharmacological properties. However, herbal medicines have limitations on low solubility and stability. A nanoparticle delivery system is a perfect form of active ingredient development, because it can mediate the increase in solubility, dissolution rate, and strength of a targeted delivery system. This study aimed to make and test the formulation of the ethanol and ethyl acetate fraction from green tea leaves in the form of a nanoparticle delivery system using chitosan biopolymer as the primary carrier polymer combined with sodium tripolyphosphate as a crosslinker and then carried out the tests on the MDA-MB-231 breast cancer cell line. The results showed that the particle size value was 199.7 nm, the zeta potential was-56.7 mV, and the polydispersity index was 0.337. X-ray diffraction and differential scanning calorimetry test results showed that the fraction was perfectly dispersed molecularly in the nanoparticle system. The results of the cytotoxic test on the MDA-MB-231 breast cancer cell line obtained IC50 values for both fractions, namely 10.70 μg/mL (nano ethanol fraction) and 12.72 μg/mL (nano ethyl acetate fraction). This result showed a significant increase in anticancer activity in both fractions compared to those not formulated ( < 0.05). These results also show that the tea fraction formulated in a nanoparticle delivery system has a great potential as a new therapeutic agent for breast cancer.

摘要

绿茶具有诸多益处。其主要潜在成分是表没食子儿茶素没食子酸酯,具有多种生物活性和药理特性。然而,草药存在溶解度和稳定性低的局限性。纳米颗粒递送系统是活性成分开发的理想形式,因为它可以介导靶向递送系统的溶解度、溶解速率和强度的增加。本研究旨在制备并测试以壳聚糖生物聚合物作为主要载体聚合物、三聚磷酸钠作为交联剂的纳米颗粒递送系统形式的绿茶叶乙醇和乙酸乙酯馏分的制剂,然后在MDA-MB-231乳腺癌细胞系上进行测试。结果表明,粒径值为199.7 nm,zeta电位为 -56.7 mV,多分散指数为0.337。X射线衍射和差示扫描量热法测试结果表明,该馏分在纳米颗粒系统中分子水平上完美分散。对MDA-MB-231乳腺癌细胞系的细胞毒性测试结果显示,两种馏分的IC50值分别为10.70 μg/mL(纳米乙醇馏分)和12.72 μg/mL(纳米乙酸乙酯馏分)。该结果表明,与未制成制剂的馏分相比,两种馏分的抗癌活性均显著增加(P < 0.05)。这些结果还表明,以纳米颗粒递送系统形式制备的绿茶馏分作为乳腺癌的新型治疗剂具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f517/9784050/d97d3ffa684c/JAPTR-13-301-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验